Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in IL-1β-activated human mast cells were inhibited by Baicalein via regulation of the NF-κB pathway

Clinical and Molecular Allergy

Volumn 10, Issue , 2012, Pages

  Chi, David S ^a   Lin, Ta Chang ^b   Hall, Kenton ^a   Ha, Tuanzhu ^a   Li, Chuanfu ^a   Wu, Zong D ^b   Soike, Thomas ^a   Krishnaswamy, Guha ^a  

^a East Tennessee State University   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Baicalein; Cigarette smoking; I B phosphorylation and degradation; Il 6; Il 8; Mast cell; NF b activation

Indexed keywords

ANTIINFLAMMATORY AGENT; BAICALEIN; CIGARETTE SMOKE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAST CELL;

EID: 84862802977     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-10-3     Document Type: Article

References (43)

1. Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, Chi DS. The human mast cell: functions in physiology and disease. Front Biosci 2001, 6:D1109-1127. 10.2741/krishnas, 11532608.
2. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol 2006, 315:13-34.
3. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007, 217:304-328. 10.1111/j.1600-065X.2007.00520.x, 17498068.
4. Igarashi Y, Goldrich MS, Kaliner MA, Irani AM, Schwartz LB, White MV. Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol 1995, 95:716-725. 10.1016/S0091-6749(95)70177-X, 7897155.
5. Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003, 58:528-532. 10.1136/thorax.58.6.528, 1746707, 12775868.
6. Garriga MM, Friedman MM, Metcalfe DD. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 1988, 82:425-432. 10.1016/0091-6749(88)90015-2, 3170991.
7. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692. 10.1126/science.1073176, 12215644.
8. Castells M. Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am 2006, 26:465-485. 10.1016/j.iac.2006.05.005, 16931289.
9. Baumann H, Jahreis GP, Sauder DN, Koj A. Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J Biol Chem 1984, 259:7331-7342.
10. Okada M, Sakaguchi N, Yoshimura N, Hara H, Shimizu K, Yoshida N, Yoshizaki K, Kishimoto S, Yamamura Y, Kishimoto T. B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med 1983, 157:583-590. 10.1084/jem.157.2.583, 2186927, 6600487.
11. Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997, 66:101-195.
12. Cannon JG, Evans WJ, Hughes VA, Meredith CN, Dinarello CA. Physiological mechanisms contributing to increased interleukin-1 secretion. J Appl Physiol 1986, 61:1869-1874.
13. Chi DS, Fitzgerald SM, Pitts S, Cantor K, King E, Lee SA, Huang SK, Krishnaswamy G. MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response. BMC Immunol 2004, 5:22. 10.1186/1471-2172-5-22, 521685, 15383152.
14. Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, Krishnaswamy G. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. Am J Respir Cell Mol Biol 2004, 31:283-291. 10.1165/rcmb.2004-0089OC, 15191916.
15. Lusis AJ. Atherosclerosis. Nature 2000, 407:233-241. 10.1038/35025203, 2826222, 11001066.
16. Lin CC, Shieh DE. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 1996, 24:31-36. 10.1142/S0192415X96000050, 8739179.
17. Wakabayashi I. Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol Toxicol 1999, 84:288-291. 10.1111/j.1600-0773.1999.tb01496.x, 10401731.
18. Li FQ, Wang T, Pei Z, Liu B, Hong JS. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J Neural Transm 2005, 112:331-347. 10.1007/s00702-004-0213-0, 15503194.
19. Woo KJ, Lim JH, Suh SI, Kwon YK, Shin SW, Kim SC, Choi YH, Park JW, Kwon TK. Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 2006, 211:359-368. 10.1016/j.imbio.2006.02.002, 16716805.
20. Cheng PY, Lee YM, Wu YS, Chang TW, Jin JS, Yen MH. Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem Pharmacol 2007, 73:793-804. 10.1016/j.bcp.2006.11.025, 17182007.
21. Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS. Baicalein inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway. Clinical Molecular Allergy 2007, 5:5.
22. Fitzgerald SM, Lee SA, Hall HK, Chi DS, Krishnaswamy G. Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact. Am J Respir Cell Mol Biol 2004, 30:585-593.
23. Fitzgerald SM, Chi DS, Hall HK, Reynolds SA, Aramide O, Lee SA, Krishnaswamy G. GM-CSF induction in human lung fibroblasts by IL-1beta, TNF-alpha, and macrophage contact. J Interferon Cytokine Res 2003, 23:57-65. 10.1089/107999003321455453, 12744771.
24. Li C, Browder W, Kao RL. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am J Physiol 1999, 276:H543-552.
25. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W, Williams DL. Modulating Toll-like receptor mediated signaling by (1-- > 3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res 2004, 61:538-547. 10.1016/j.cardiores.2003.09.007, 14962484.
26. Li C, Kao RL, Ha T, Kelley J, Browder IW, Williams DL. Early activation of IKKbeta during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol 2001, 280:H1264-1271.
27. Li C, Ha T, Liu L, Browder W, Kao RL. Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. Surgery 2000, 127:161-169. 10.1067/msy.2000.101582, 10686981.
28. Hsieh CJ, Hall K, Krishnaswamy G, Chi DS. Differential effects of berberine, baicalein, and triptolide on cytokine production from IL-1 -activated mast cells [abstract]. J Immunol 2007, 178:95.28.
29. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996, 87:13-20. 10.1016/S0092-8674(00)81318-5, 8858144.
30. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683. 10.1146/annurev.immunol.14.1.649, 8717528.
31. Baeuerle PA, Baichwal VR. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997, 65:111-137.
32. Henz BM, Maurer M, Lippert U, Worm M, Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001, 10:1-10. 10.1034/j.1600-0625.2001.100101.x, 11168574.
33. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 1999, 163:3474-3483.
34. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995, 270:283-286. 10.1126/science.270.5234.283, 7569975.
35. Kuhn H, O'Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 2006, 45:334-356. 10.1016/j.plipres.2006.02.003, 16678271.
36. George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 2001, 104:1646-1650. 10.1161/hc3901.095772, 11581143.
37. Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol 2004, 24:821-827.
38. Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z. Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. Heart 2005, 91:1203-1208. 10.1136/hrt.2004.046292, 1769084, 15774612.
39. Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumberg RS, Nagai R, Matsuhashi N. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 2001, 120:460-469. 10.1053/gast.2001.21191, 11159886.
40. Appel S, Mirakaj V, Bringmann A, Weck MM, Grunebach F, Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 2005, 106:3888-3894. 10.1182/blood-2004-12-4709, 16105976.
41. Kempuraj D, Castellani ML, Petrarca C, Frydas S, Conti P, Theoharides TC, Vecchiet J. Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Clin Exp Med 2006, 6:150-156. 10.1007/s10238-006-0114-7, 17191106.
42. Castellani ML, Kempuraj D, Frydas S, Theoharides TC, Simeonidou I, Conti P, Vecchiet J. Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation 2006, 13:179-186. 10.1159/000098131, 17191019.
43. Kandere-Grzybowska K, Kempuraj D, Cao J, Cetrulo CL, Theoharides TC. Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol 2006, 148:208-215. 10.1038/sj.bjp.0706695, 1617055, 16532021.